Bluebird Bio, Inc. logo

Bluebird Bio, Inc. Share Price BLUE

$4.97

Last updated on

Bell Icon

This instrument is not available for trading on the INDmoney app on 30 May 2025

Check the interactive Bluebird Bio, Inc. Stock chart to analyse performance

Bluebird Bio, Inc. Key Stats

Check Bluebird Bio, Inc. key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$4.97
Open
$4.74
Market Capitalization
$48.7M
Today's Volume
$1.2M
Revenue TTM
$103.9M
EBITDA
$-149.2M
Earnings Per Share (EPS)
$-20.59
Profit Margin
-192.39%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-546.54%

Global Institutional Holdings in Bluebird Bio, Inc.

  • Name

    Holdings %

  • BlackRock Inc

    7.13%

  • Vanguard Group Inc

    5.29%

  • TANG CAPITAL MANAGEMENT LLC

    4.08%

  • Geode Capital Management, LLC

    2.51%

  • State Street Corp

    2.00%

  • EQUITEC PROPRIETARY MARKETS, LLC

    1.13%

Analyst Recommendation on Bluebird Bio, Inc. Stock

Rating
Trend

Buy

    50%Buy

    40%Hold

    10%Sell

Based on 20 Wall street analysts offering stock ratings for Bluebird Bio, Inc.(by analysts ranked 0 to 5 stars)

About Bluebird Bio, Inc.

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for curative severe genetic diseases in the United States. The company's product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; LYFGENIA (lovotibeglogene autotemcel) for the treatment of sickle cell disease (SCD) and a history of vaso-occlusive events; and SKYSONA (elivaldogene autotemcel) to treat cerebral adrenoleukodystrophy. Its clinical development programs include HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Somerville, Massachusetts.
Organization
Bluebird Bio, Inc.
Employees
248
CEO
Mr. Andrew Obenshain
Industry
Health Technology

Key Management of Bluebird Bio, Inc.

NameTitle
Mr. Andrew Obenshain
President, CEO & Director
Mr. Thomas J. Klima
Chief Commercial & Operating Officer
Mr. Joseph D. Vittiglio Esq., J.D.
Chief Legal & Business Officer and Secretary
Mr. Oliver James Sterling III
CFO & Principal Accounting Officer
Ms. Andrea Walton
Chief People Officer
Dr. Richard A. Colvin M.D., Ph.D.
Chief Medical Officer
Mr. Scott Shoemaker
Senior Vice President of Technical Operations

Important FAQs about investing in BLUE Stock from India :

What is Bluebird Bio, Inc. share price today?

Bluebird Bio, Inc. share price today is $4.97 as on at the close of the market. Bluebird Bio, Inc. share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Bluebird Bio, Inc. share?

Bluebird Bio, Inc. share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Bluebird Bio, Inc. stock price today i.e. is closed at $4.97, lower by 96.71% versus the 52 week high.

How to invest in Bluebird Bio, Inc. Stock (BLUE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bluebird Bio, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bluebird Bio, Inc. Shares that will get you 0.3018 shares as per Bluebird Bio, Inc. share price of $4.97 per share as on May 30, 2025 at 12:00 am IST.

What is the minimum amount required to buy Bluebird Bio, Inc. Stock (BLUE) from India?

Indian investors can start investing in Bluebird Bio, Inc. (BLUE) shares with as little as ₹94.49 or $1 (as of June 26, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹944.90 in Bluebird Bio, Inc. stock (as per the Rupee-Dollar exchange rate as on June 26, 2026). Based on Bluebird Bio, Inc. share’s latest price of $4.97 as on May 30, 2025 at 12:00 am IST, you will get 2.0121 shares of Bluebird Bio, Inc.. Learn more about fractional shares .

What are the returns that Bluebird Bio, Inc. has given to Indian investors in the last 5 years?

Bluebird Bio, Inc. stock has given 0.0% share price returns and 27.31% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?